Hipertensión arterial sistémica: Fisiopatología

ANALES DEL SISTEMA SANITARIO DE NAVARRA

Suplemento 3

Hipertensión arterial sistémica: Fisiopatología

M.S. Alcasena, J. Martínez, J. Romero

Servicio de Cardiología, Hospital de Navarra, Pamplona.

BIBLIOGRAFÍA

1. Kaplan NM. Systemic hypertension: mechanisms and diagnosis. En: Braunwald E, editor. Heart disease. A textbook of Cardiovascular Medicine. Philadelphia: Saunders Co, 1997: 807-839.

2. Dustan HP. Pathophysiology of systemic hypertension. En: Hurst JW editor. The Heart, arteries and veins. New York: McGraw Hill, 1990: 1140-1150.

3. Navar LG. The kidney in blood pressure regulation and developement of hypertension. Med Clin North Am 1997; 81: 1165-1197.

4. Seravalle G, Cattaneo BM, Giannattasio C, Perondi R, Saino A, Grassi G et al. RAA system and cardiovascular control in normal subjects, hypertensives and patients with congestive heart failure. J Hum Hypertens 1993; 7 (Suppl 2): S13-S18.

5. Kang PM, Landau AJ, Eberhardt RT, Frishman WH Angiotensin II receptor antagonists: A new approch to blockade of the renin-angiotensin system. Am Heart J 1994; 127: 1388-1401.

6. Lees KR, Macfadyen RJ, Doig JK, Reid JL. Role of angiotensin in the extravascular system. J Hum Hypertens 1993: 7 (Suppl 2): S7-S12.

7. Timmermans PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993: 45: 205-251.

8. Dzau VJ, Sasamura H, Hein L. Heterogeneity of angiotensin synthetic pathways and receptor subtypes: Physiological and pharmacological implications. J Hypertension 1993; 11 (Suppl 3): S13-S18.

9. Goldfarb DA, Novick AC The renin-angiotensin system: revised concepts and implication for renal function. Urology 1994; 43: 572-583.

10. Fouad-Tarazi F. Hypertension hemodynamics. Med Clin North Am 1997; 81: 1131-1145.

11. Omvik P. Hemodynamic Patterns of Untreated Hypertensive Disease. En: Laragh JH, and Brenner BM, editores. Hypertension: Pathophysiology, Diagnosis, and Management. New York: Raven Press, Ltd, 1990: 305-327.

12. Lund-Johansen P. New thinking on the hemodynamics of hypertension. Curr Opin Cardiol 1994; 9: 505-511.

13. Frohlich ED. Current clinical pathophysiologic considerations in essential hypertension. Med Clin North Am 1997: 81; 1113-1129.

14. Safar ME, Frohlich ED. The arterial system in hypertension. A prospective view. Hypertension 1995; 26: 10-14.

15. Ward R. Familial aggregation and genetic epidemiology of blood pressure. En: Laragh JH, Brenner BM, editores. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press 1990: 81-100.

16. Harrap SB. Hypertension: genes versus environment. Lancet; 1994, 344: 169-171.

17. Schork NJ. Genetically complex cardiovascular traits. Origins, problems and potentials solutions. Hypertension 1997; 29 (Part 2): 145-149.

18. Ganten D, Takahashi S, Lindpaintner K, Mullins J. Genetic basis of hypertension. The renin-angiotensin paradigm. Hypertension 1991; 18 (Suppl III): 109-114.

19. Hollenberg NK. Genes, hypertension and intermediate phenotypes. Curr Opin Cardiol 1966; 11: 457-463.

20. Law CM, De Sweit M, Osmond C, Fayers PM, Barker DJP, Cruddas AM, et al. Initiation of hypertension in utero and its amplification throughout life. Br Med J 1993; 306: 24-27.

21. Martyn CN, Greenwald SE. Impaired synthesis of elastin in walls of aorta and large conduit arteries during early developement as an initiating event in pathogenesis of systemic hypertension. Lancet 1997; 350: 953-955.

22. Hollemberg NK, Martínez G, Mccullough M et al. Hypertension 1977: 29 (Part 2): 171-176.

23. Swales JD. Functional disturbance of the cell membrane in hypertension. J Hypertens 1990; 8: S203-S211.

24. Uzu T, Kazembe FS, Ishikawa K, Nakamura S, Inenaga T, Kimura G. High sodium sensitivity implicates nocturnal hypertension in essential hypertension. Hypertension 1996; 28: 139-142.

25. Dzauvj, Gibbons GH, Cooke JP, Omoigui N. Vascular biology and medicine in 1990s: Scope, concepts, potentials and perspectives. Circulation 1993; 87: 705-719.

26. Chang N-C, Lai Z-Y, Chan Pwang T-C. Left ventricular filling profiles in young white-coat hypertensive patients without hypertrophy. Hypertension 1997; 30 (Part 2): 746-752.

27. Ruzicka M, Leenen FHH. Update on local cardiac renin-angiotensin system. Curr Opin Cardiol 1997: 12: 347-353.

28. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994; 330: 1431-1438.

29. Vane JR, Änggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.

30. Susic D. Hypertension, aging, and atherosclerosis. The endotelial interface. Med Clin North Am 1997; 81: 1231-1240.

31. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserver endotheliun-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036-1040.

32. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468-1474.

33. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M. Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension 1997; 30 (Part 1): 405-408.

34. Cuevas Sánchez P, Saez de Tejada I, Giménez-Gallego G. Biología molecular de la hipertensión esencial. En: JL Palma Gamiz., E Alegria Ezquerra, F de Lombera Romero, editores. Hipertensión y cardiopatía hipertensiva. Madrid, Mosby-Doyma 1996; 35-39.

35. Zimmerman RS. Hormonal and humeral considerations in hypertension disease. Med Clin North Am 1997; 81: 1213-1229.

36. Petrie JR, Ueda S, Webb DJ, Elliot HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. Circulation 1996; 93: 1331-1333.

37. Sung BH, Wilson MF, Izzo JL, Ramírez L, Dandona P. Moderately obese, insulin-resistent woman exibit abnormal vascular reactivity to stress. Hypertension 1997; 30: 848-853.

38. Lender D, Arauz-Pacheco C, Adams-Huet B, Raskin P. Essential hypertension is associated with decreased insulin clearance and insulin resistence. Hypertension 1997; 29: 111-114.

39. Januszewicz A. The natriuretic peptides in hypertension. Curr Opin Cardiol 1995; 10: 495-500.

40. Aranda P, Aranda FJ. Bloqueantes de los canales de calcio en la mujer hipertensa postmenopáusica. En: Aranda Lara P, Coca Payeras A, Palma Gámiz JL, Plaza Celemin L, editores. Cuadernos Latinoamericanos de Hipertensión. Madrid: Doyma 1997; 1: 145-150.

41. Williams GH. Hypertensive vascular disease. En: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, editores. Harrison´s Principles of Internal Medicine. New York: McGraw-Hill.